MedPath

Comparison between two groups of drugs for prevention of nausea & vomiting in women after surgery on uterus or ovaries.

Phase 3
Conditions
Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
Registration Number
CTRI/2023/08/056860
Lead Sponsor
Post Graduate Institute of Medical Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA physical status I/II

Scheduled for laparoscopic procedures >1hr duration

Exclusion Criteria

1. History of hypersensitivity or allergic reaction to ondansetron or haloperidol

2. Established diagnosis or family history of congenital long QT syndrome

3. Parkinsons disease

4. Use of anti emetic within 24 hours of surgery

5. Use of antipsychotic drugs

6. Pregnant patients

7. Obese patients (BMI >30)

8. Electrolyte abnormalities

9. Haemodynamic instability in the peri operative period

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of nausea using 11 point verbal numerical rating scale & number of episodes of vomiting <br/ ><br>Timepoint: First 24 hours following laparoscopic gynaecological procedure
Secondary Outcome Measures
NameTimeMethod
corrected QT intervalTimepoint: within first hour following laparoscopic gynaecological procedure;Extent of sedationTimepoint: First 24 hours following laparoscopic gynaecological procedure, using Observers assessment of alertness/sedation scale;Incidence of delirium using confusion assessment method (CAM)Timepoint: First 24 hours following laparoscopic gynaecological procedure;Post operative analgesiaTimepoint: First 24 hours following laparoscopic gynaecological procedure, using Visual Analog Score (VAS);Requirement of rescue antiemeticTimepoint: First 24 hours following laparoscopic gynaecological procedure, & name of drug administered;Time to administration of rescue antiemeticTimepoint: from end of procedure to occurrence of first episode of vomiting or sensation of nausea
© Copyright 2025. All Rights Reserved by MedPath